1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Cancer Drug News 12 JANUARY 2015

Cancer Drug News 12 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Incentives Will Continue To Generate Interest In Orphan Diseases
Industry Trend Analysis - SABCS Highlights Focus On HER2- And PD-1-Targeting Drugs For BC
Industry Brief - KHK/Syndax Sign Deal To Develop Entinostat In Japan/Korea
Industry Brief - Pfizer Updates On Ibrance's Progress
Industry Brief - Kite's KTE-CI9 Gains EU Orphan Medicinal Product Designation For DLBCL
Industry Brief - Soligenix' SGX301 Gains FDA Fast Track Designation For First-Line CTCL
Industry Brief - Imbruvica Shows Efficacy In High-Risk CLL Patients
Industry Brief - Gamida's NiCord Gains ODD In US/Europe
Industry Brief - Chipscreen Receives Chinese Approval For Epidaza In PTCL
Industry Brief - Selinexor Granted ODD For Multiple Myeloma
Industry Brief - Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
Industry Brief - QIAGEN's Liquid Biopsy For Iressa Secures CE Marking
Industry Brief - MedImmune/Omnis Sign Licensing Deal For Oncolytic Viruses In Immuno-Oncology
Industry Brief - Lion Submits IND For LN-144 Phase II MM Trial
Industry Brief - Nivolumab Receives PMI Status For Advanced Melanoma
Industry Brief - Sobi/Exelixis Extend Cometriq Distribution Agreement
Industry Brief - Amgen/Kite Collaborate To Develop CAR T-Cell Immunotherapies
Industry Brief - Otsuka Reports Termination Of Contracts With OTS/Fuso Pharmaceutical Industries
Industry Brief - Mersana/Takeda Expand Fleximer-ADC Collaboration
Industry Trend Analysis - Incyte/Agenus Collaboration Raises Profile In Immuno-Oncology Market
Industry Brief - First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
Industry Brief - Helsinn Reaches Palonosetron Settlement With Sandoz
Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
Industry Brief - Cardio3 Enters Immuno-Oncology Space With OnCyte Acquisition
Industry Brief - Cipher Snaps Up Melanovus Oncology's Assets

Table Of Contents

Cancer Drug News 12 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Flat-Rate Access to R&D Database & Reports from La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing

  • $ 8470
  • Industry report
  • November 2016
  • by La Merie Publishing

Flat-Rate Access to R&D Database & Reports from La Merie Publishing - R&D Drug Pipeline Database: 1-Year Subscription - Flat-Rate Subscription to La Merie Publishing Reports & News Services A one-yea ...

Bioprinting: Technologies and Global Markets

Bioprinting: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Understand market dynamics of bioprinting technologies, applications, and end-user industries. - Assess specific bioprinting-related industries, including 3-D cell culture; bioinks; ...

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.